Alexander R. Engelmann

Dr. Alexander R. Engelmann

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2024 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
AKAlan W. Kong
Alan W. Kong
Alexander R. EngelmannAlexander R. Engelmann
Alexander R. Engelmann
MHMahdieh Hosseini
Mahdieh Hosseini
LBLaura Bonelli
Laura Bonelli
This report details the characteristics of a case of bilateral optic neuropathy during treatment with oral lorlatinib for ALK-positive metastatic adenocarcinoma of the lung. A 57-year-old woman with metastatic adenocarcinoma of the lung receiving treatment with lorlatinib presented to the ophthalmology urgent care with bilateral loss of vision that had progressed to no light perception over the previous 2 weeks. She was hospitalized for an extensive autoimmune, infectious, neoplastic, and paraneoplastic workup, which revealed enhancement of both optic nerves extending up to the optic chiasm and an area of restricted diffusion in the splenium of the corpus callosum on MRI. Lorlatinib was discontinued by her oncologist and she received treatment with five days of pulse-dose intravenous solumedrol as well as five days of plasmapheresis with gradual improvement in her vision. In follow-up, her vision had improved to 20/40 and 20/30. There have been few reports describing vision loss associated with lorlatinib, an ALK/ROS1 targeted tyrosine kinase inhibitor used to treat metastatic lung adenocarcinoma. This report details the characteristics of a case of bilateral retrobulbar optic neuropathy as well as the treatment and recovery of such a case. Further exploration is needed in order to improve our understanding of the pathogenesis of this rare but potentially devastating adverse effect.

1 March 2025 in Toxicology Reports
Verified
Journal Article
Open access
Alexander R. EngelmannAlexander R. Engelmann
Alexander R. Engelmann
NPNutsa Pargalava
Nutsa Pargalava
ASAlfredo A Sadun
Alfredo A Sadun
Hydrogen peroxide (HP) poisoning is rare but potentially life-threatening. It can cause tissue damage through oxygen emboli and reactive oxygen species (ROS). This is the first reported case of blindness caused by cerebral infarctions involving the visual pathway due to oxygen emboli from HP ingestion. A monocular patient presented with profound vision loss and no apparent pharyngeal mucosal injury following ingestion of commercial-grade (35 %) HP. CT imaging revealed gastric wall edema and gas in the portal venous system, suggesting gas emboli. Post-treatment MRI of the brain and orbits with and without contrast confirmed multifocal embolic infarcts along the visual pathway, and transcranial doppler studies identified moderate right-to-left shunting to explain the paradoxical emboli. The patient received hyperbaric oxygen therapy, resulting in a rapid improvement in visual acuity from hand motion to 20/20 and near-total resolution of visual field loss. Remarkably, this recovery occurred despite treatment initiation more than 24 h after symptom onset. This case emphasizes the importance of timely recognition and management of HP poisoning. In the authors' minds it also raised questions about the routine use of 100 % oxygen in hyperbaric therapy due to potential additional oxidative stress. It is the authors' opinion that further research should be done to validate treatment protocols and further interrogate possible risks associated with reactive oxygen species and oxygen toxicity.

Verified
Journal Article
Open access
PDF file
Alexander R. EngelmannAlexander R. Engelmann
Alexander R. Engelmann
KSKailash Mordecai Singh
Kailash Mordecai Singh
JZJiachen Zhuo
Jiachen Zhuo
NDNeha Datta
Neha Datta
ASAlfredo A Sadun
Alfredo A Sadun
SMShannath L Merbs
Shannath L Merbs
Orbital floor fractures may cause long-term functional and esthetic impairments. Diplopia due to impaired function of the inferior rectus muscle is frequently an indication for surgical repair, but some cases, such as those where the diagnosis has been delayed or a previous attempt at repair has been made, may not always be amenable to surgical correction. It is advantageous for the surgeon to know whether the proper function of the inferior rectus muscle can be restored for the purposes of surgical planning and prognostication. The authors hypothesized that real-time MRI could be used to characterize the appearance of the inferior rectus muscle in a way that would facilitate future analysis of inferior rectus function in patients with diplopia due to orbital floor fractures. Real-time MRI was performed on 10 volunteer participants with normal ophthalmic function and orbital anatomy to assess inferior rectus appearance during vertical duction testing. ImageJ software was used to measure and record characteristics of the inferior rectus muscle, viewed in a quasi-sagittal plane. The ratios evaluated included inferior rectus muscle length in upgaze versus downgaze (UDR, mean 1.58) as well as inferior rectus muscle length versus distance from inferior rectus origin to inferior rectus inflection point in upgaze (LIR, mean 1.30) and downgaze (mean 1.20). These values were found to be conserved between orbits and individuals. This data offers quantitative insight regarding inferior rectus muscle appearance across the full arc of vertical gaze in healthy individuals. We plan to use this normative baseline dataset as a comparison for future phases of this project, using real-time MRI to evaluate traumatized orbits with diplopia and derangement of the inferior rectus muscle.

7 August 2024 in Current Surgery Reports
Verified
Journal Article
Closed access
PDF file
Alexander R. EngelmannAlexander R. Engelmann
Alexander R. Engelmann
SMShannath L Merbs
Shannath L Merbs